These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pathology of peripheral neuroblastic tumors]. Wang L; He LJ; Shimada H Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533 [No Abstract] [Full Text] [Related]
6. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors. Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328 [TBL] [Abstract][Full Text] [Related]
7. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data. Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data. Tabyaoui I; Tahiri-Jouti N; Serhier Z; Bennani-Othmani M; Sibai H; Itri M; Benchekroun S; Zamiati S Diagn Pathol; 2013 Feb; 8():39. PubMed ID: 23445749 [TBL] [Abstract][Full Text] [Related]
9. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206 [TBL] [Abstract][Full Text] [Related]
10. Frequency of ALK and GD2 Expression in Neuroblastoma. Aygün Z; Batur Ş; Emre Ş; Celkan T; Özman O; Comunoglu N Fetal Pediatr Pathol; 2019 Aug; 38(4):326-334. PubMed ID: 30955398 [No Abstract] [Full Text] [Related]
11. Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. Yuan X; Seneviratne JA; Du S; Xu Y; Chen Y; Jin Q; Jin X; Balachandran A; Huang S; Xu Y; Zhai Y; Lu L; Tang M; Dong Y; Cheung BB; Marshall GM; Shi W; Carter DR; Zhang C Cell Rep; 2022 Oct; 41(1):111455. PubMed ID: 36198269 [TBL] [Abstract][Full Text] [Related]
12. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo. Schulte JH; Pentek F; Hartmann W; Schramm A; Friedrichs N; Øra I; Koster J; Versteeg R; Kirfel J; Buettner R; Eggert A Int J Cancer; 2009 May; 124(10):2488-94. PubMed ID: 19142969 [TBL] [Abstract][Full Text] [Related]
13. Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. Santic R; Fenninger K; Graf K; Schneider R; Hauser-Kronberger C; Schilling FH; Kogner P; Ratschek M; Jones N; Sperl W; Kofler B J Mol Neurosci; 2006; 29(2):145-52. PubMed ID: 16954604 [TBL] [Abstract][Full Text] [Related]
14. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660 [TBL] [Abstract][Full Text] [Related]
15. Ganglioneuroma of the mandible resulting from metastasis of neuroblastoma. Patterson AR; Barker CS; Loukota RA; Spencer J Int J Oral Maxillofac Surg; 2009 Feb; 38(2):196-8. PubMed ID: 19019630 [TBL] [Abstract][Full Text] [Related]
16. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours. Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139 [TBL] [Abstract][Full Text] [Related]
17. The International Neuroblastoma Pathology Classification (the Shimada system). Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273 [TBL] [Abstract][Full Text] [Related]
18. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors. Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801 [TBL] [Abstract][Full Text] [Related]
19. Tumors of the neuroblastoma group. Shimada H Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Wang YM; Li YW; Sheih CP; Hsu JC Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(6):420-4. PubMed ID: 8592928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]